Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Clinical trial NCT05821231 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05821231
- Sponsor
- Institut Claudius Regaud
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2026-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.